Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22185864 | 1.00 | ATM (0.38) | ATMKDM4EL3MBTL1HDAC4FAAH | |
| SCHEMBL23204746 | 0.95 | ATM (0.38) | ATMKDM4EL3MBTL1HDAC4FAAH | |
| SCHEMBL23863374 | 0.95 | ATM (0.38) | ATMKDM4EL3MBTL1FAAHALDH1A1 | |
| SCHEMBL19417149 | 0.95 | L3MBTL1 (0.39) | ATMKDM4EL3MBTL1HDAC4ALDH1A1 | |
| SCHEMBL25779686 | 0.94 | ATM (0.40) | ATMKDM4EL3MBTL1HDAC4FAAH | |
| SCHEMBL16901038 | 0.94 | ATM (0.38) | ATMKDM4EL3MBTL1HDAC4FAAH | |
| SCHEMBL24180420 | 0.93 | KDM4E (0.38) | ATMKDM4EL3MBTL1HDAC4 | |
| SCHEMBL14220693 | 0.93 | ATM (0.39) | ATMKDM4EL3MBTL1HDAC4FAAH | |
| SCHEMBL256629 | 0.92 | KDM4E (0.40) | ATMKDM4EL3MBTL1HDAC4KMT2A | |
| SCHEMBL12696243 | 0.92 | KDM4E (0.38) | ATMKDM4EL3MBTL1HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230139045-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230139045-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OXER1, OCIAD1, OR10J3 | ATM 3712/4885KDM4E 3961/4885L3MBTL1 4287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.